CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2021	Dec. 31, 2020
CURRENT ASSETS:
Cash	$ 2,276	$ 2,758
Prepaid expenses and other assets	2,806	2,306
Total current assets	5,082	5,064
Fixed assets, net of accumulated depreciation	1,173
TOTAL ASSETS	6,255	5,064
CURRENT LIABILITIES:
Accounts payable and accrued expenses	9,408	1,907
Loan payable – related party	165,145	99,316
Notes payable – related party	167,554	167,554
Total current liabilities	342,107	268,777
STOCKHOLDERS’ DECIFIT
Preferred stock, par value $0.001 per share; 10,000,0000 shares authorized; 500,000 shares issued and outstanding at September 30, 2021 and December 31, 2020	500	500
Common stock, par value $0.001 per share; 1,000,000,000 shares authorized; 32,606,582 shares issued and outstanding at September 30, 2021 and December 31, 2020	32,607	32,607
Capital deficiency	3,664,665	3,664,665
Accumulated Deficit	(4,034,294)	(3,962,155)
Total stockholder’s deficit	(335,852)	(263,713)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	6,255	5,064
Series A Preferred Stock [Member]
STOCKHOLDERS’ DECIFIT
Preferred stock, par value $0.001 per share; 10,000,0000 shares authorized; 500,000 shares issued and outstanding at September 30, 2021 and December 31, 2020	520	520
Series B Preferred Stock [Member]
STOCKHOLDERS’ DECIFIT
Preferred stock, par value $0.001 per share; 10,000,0000 shares authorized; 500,000 shares issued and outstanding at September 30, 2021 and December 31, 2020	$ 150	$ 150

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.